Kinin B1 Receptor in Adipocytes Regulates Glucose Tolerance and Predisposition to Obesity

Background Kinins participate in the pathophysiology of obesity and type 2 diabetes by mechanisms which are not fully understood. Kinin B1 receptor knockout mice (B1 −/−) are leaner and exhibit improved insulin sensitivity. Methodology/Principal Findings Here we show that kinin B1 receptors in adipocytes play a role in controlling whole body insulin action and glucose homeostasis. Adipocytes isolated from mouse white adipose tissue (WAT) constitutively express kinin B1 receptors. In these cells, treatment with the B1 receptor agonist des-Arg9-bradykinin improved insulin signaling, GLUT4 translocation, and glucose uptake. Adipocytes from B1 −/− mice showed reduced GLUT4 expression and impaired glucose uptake at both basal and insulin-stimulated states. To investigate the consequences of these phenomena to whole body metabolism, we generated mice where the expression of the kinin B1 receptor was limited to cells of the adipose tissue (aP2-B1/B1 −/−). Similarly to B1 −/− mice, aP2-B1/B1 −/− mice were leaner than wild type controls. However, exclusive expression of the kinin B1 receptor in adipose tissue completely rescued the improved systemic insulin sensitivity phenotype of B1 −/− mice. Adipose tissue gene expression analysis also revealed that genes involved in insulin signaling were significantly affected by the presence of the kinin B1 receptor in adipose tissue. In agreement, GLUT4 expression and glucose uptake were increased in fat tissue of aP2-B1/B1 −/− when compared to B1 −/− mice. When subjected to high fat diet, aP2-B1/B1 −/− mice gained more weight than B1 −/− littermates, becoming as obese as the wild types. Conclusions/Significance Thus, kinin B1 receptor participates in the modulation of insulin action in adipocytes, contributing to systemic insulin sensitivity and predisposition to obesity.

[1]  R. Couture,et al.  Blockade of kinin B1 receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance , 2012, Diabetes, obesity & metabolism.

[2]  S. Kasif,et al.  A Systems Biology Approach Identifies Inflammatory Abnormalities Between Mouse Strains Prior to Development of Metabolic Disease , 2010, Diabetes.

[3]  M. Mori,et al.  Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E , 2009, Journal of Molecular Medicine.

[4]  S. B. Peres,et al.  Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes , 2008, Journal of pineal research.

[5]  M. Mori,et al.  Kinin B1 Receptor Deficiency Leads to Leptin Hypersensitivity and Resistance to Obesity , 2008, Diabetes.

[6]  H. Gavras,et al.  Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct: Role of the Kinin B1 and B2 Receptors , 2008, Hypertension.

[7]  L. Cassis,et al.  Local adipose tissue renin-angiotensin system , 2008, Current hypertension reports.

[8]  H. Waki,et al.  Endocrine functions of adipose tissue. , 2007, Annual review of pathology.

[9]  I. G. Fantus,et al.  Bradykinin Augments Insulin-Stimulated Glucose Transport in Rat Adipocytes via Endothelial Nitric Oxide Synthase–Mediated Inhibition of Jun NH2-Terminal Kinase , 2006, Diabetes.

[10]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[11]  M. Mori,et al.  Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function , 2006, Biological chemistry.

[12]  J. Flier,et al.  Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. , 2006, Diabetes.

[13]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  F. Marceau,et al.  International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences , 2005, Pharmacological Reviews.

[15]  E. Fernandes,et al.  Kinin B1 receptors: key G‐protein‐coupled receptors and their role in inflammatory and painful processes , 2004, British journal of pharmacology.

[16]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[17]  P. Arner.  The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones , 2003, Trends in Endocrinology & Metabolism.

[18]  C. Kahn,et al.  Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. , 2002, Developmental cell.

[19]  Haiyan Xu,et al.  Exclusive Action of Transmembrane TNFα in Adipose Tissue Leads to Reduced Adipose Mass and Local But Not Systemic Insulin Resistance. , 2002, Endocrinology.

[20]  H. Gavras,et al.  Role of the B2 Receptor of Bradykinin in Insulin Sensitivity , 2001, Hypertension.

[21]  T. Tai,et al.  Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[23]  J. Beattie,et al.  Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ , 2001, Proceedings of the Nutrition Society.

[24]  H. Lodish,et al.  Insulin-Responsive Compartments Containing GLUT4 in 3T3-L1 and CHO Cells: Regulation by Amino Acid Concentrations , 2001, Molecular and Cellular Biology.

[25]  T. Walther,et al.  Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Carattino,et al.  The involvement of kallikrein-kinin system in diabetes type I (insulitis). , 1999, Immunopharmacology.

[27]  Y. Nakaya,et al.  Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. , 1998, Diabetes.

[28]  M. Shichiri,et al.  Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts. , 1998, European journal of endocrinology.

[29]  M. Shichiri,et al.  Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway , 1996, Diabetologia.

[30]  S. Jacob,et al.  Potential Role of Bradykinin in Forearm Muscle Metabolism in Humans , 1996, Diabetes.

[31]  W. Garvey,et al.  Biological Actions of Insulin Are Differentially Regulated by Glucose and Insulin in Primary Cultured Adipocytes: Chronic Ability to Increase Glycogen Synthase Activity , 1994, Diabetes.

[32]  J. W. Parce,et al.  The cytosensor microphysiometer: biological applications of silicon technology. , 1992, Science.

[33]  K. Bhoola,et al.  Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.

[34]  B. Spiegelman,et al.  A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H. Motulsky,et al.  Calculating receptor number from binding experiments using same compound as radioligand and competitor. , 1989, Trends in pharmacological sciences.

[36]  M. Wicklmayr,et al.  [Effect of bradykinin on muscular glucose uptake in man (author's transl)]. , 1977, Klinische Wochenschrift.

[37]  M. Rodbell.  METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. , 1964, The Journal of biological chemistry.

[38]  欧阳珍.  Role of the N , 2009 .

[39]  J. Carvalheira,et al.  L-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity , 2007 .

[40]  Haiyan Xu,et al.  Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. , 2002, Endocrinology.